SwipeRx was established in 2014 by CEO Farouk Meralli to address the fragmented pharmaceutical value chain in Southeast Asia.
SwipeRx does so by making bulk purchases on behalf of a network of pharmacies. Its mission is to improve the quality, accessibility, and affordability of healthcare in the region. It also aspires to empower pharmacies to fulfil their roles as centres of primary healthcare in local communities by providing high-quality services and products.
Meralli was selective with who he brought onto SwipeRx’s capitalisation table, which includes corporates and impact and non-impact-oriented investors – he consciously chose investors who backed its North Star and sought commercial returns. SwipeRx’s impact investors, such as Patamar Capital and the Global Innovation Fund, sought financial returns, whilst its commercial investors, such as Susquehanna International Group or Johnson & Johnson from the United States, valued its impact mission.
SwipeRx platform helps pharmacists improve the quality of care they can provide by building professional networks, and providing access to accredited drug information and educational courses. Today, the SwipeRx platform is home to the largest community for pharmacy professionals in Southeast Asia, connecting over 235,000 professionals across more than 45,000 pharmacies in Indonesia, the Philippines, Vietnam, Malaysia, Thailand, and Cambodia.